5-MeO-AET

This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "5-MeO-AET" – news · newspapers · books · scholar · JSTOR (July 2022)

5-MeO-AET

Legal status
Legal status	DE: NpSG (Industrial and scientific use only) UK: Class A
Identifiers
IUPAC name 1-(5-methoxy-1H-indol-3-yl)butan-2-amine
JSmol)	Interactive image
Melting point	201 to 203 °C (394 to 397 °F)
SMILES CCC(N)Cc2c[nH]c1ccc(cc12)OC
InChI InChI=1S/C13H18N2O/c1-3-10(14)6-9-8-15-13-5-4-11(16-2)7-12(9)13/h4-5,7-8,10,15H,3,6,14H2,1-2H3 Y Key:JHTPCKWBFLMJMQ-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

5-Methoxy-alpha-ethyltryptamine (5-MeO-α-ET) is a

Dosage

5-MeO-α-ET, when used recreationally, is usually taken orally at dosages of 50–75 mg.

Effects

5-MeO-α-ET produces

effects of this compound, thus considerable variation with regard to dosage and effects can be expected.

Dangers

There have been no reported deaths or hospitalizations from 5-MeO-α-ET, but its safety profile is unknown.

Legality

5-MeO-α-ET is unscheduled and uncontrolled in the United States, but possession and sales of 5-MeO-α-ET could be prosecuted under the

.

See also

• 4-HO-AMT
• 4-Methyl-AET
• 5-Fluoro-AET
• 5-EtO-AMT
• 5-MeO-AMT
• 7-Methyl-AET
• alpha-Ethyltryptamine
• alpha-Methyltryptamine

References